The role of nodal staging in breast cancer Past, present and future

Minerva Chirurgica

Volumn 65, Issue 5, 2010, Pages 537-546

  Hirche, C ^a,b   Mohr, Z ^a   Kneif, S ^a   Hunerbein M ^a  

^a Helios Hospital Berlin Buch   (Germany)

^b BG Trauma Center   (Germany)

Author keywords

Breast neoplasmas; Neoplasm staging; Sentinel lymph node biopsy

Indexed keywords

ARTICLE; BREAST TUMOR; CANCER STAGING; FEMALE; FORECASTING; HUMAN; LYMPH NODE METASTASIS; PATHOLOGY; SENTINEL LYMPH NODE BIOPSY;

BREAST NEOPLASMS; FEMALE; FORECASTING; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 79952075290     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7. (Pubitemid 19032001)
2. Gilchrist RK. Fundamental factors governing lymphatic spread of carcinoma. Ann Surg 1940;111:630-9.
3. Zeidman I, Buss JM: Experimental studies on the spread of cancer in the lymphatic system. I. Effectiveness of the lymph node as a barrier to the passage of embolic tumor cells. Cancer Res 1954;14:403-5.
4. Rutgers EJ. Sentinel node procedure in breast carcinoma: a valid tool to omit unnecessary axillary treatment or even more? Eur J Cancer 2004;40:182-6.
5. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000;88:608-14. (Pubitemid 30056936)
6. Stamatakos M, Stefanaki C, Kontzoglou K, Safioleas M. Sentinel lymph node biopsy in breast cancer: a systematic review. Onkologie 2010;33:121-6.
7. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-9.
8. Langer I, Guller U, Hsu-Schmitz SF, Ladewig A, Viehl CT, Moch H et al. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Eur J Surg Oncol 2008.
9. Halsted WS. I. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. Ann Surg 1894;20:497-555.
10. Patey DH, Dyson WH. The prognosis of carcinoma of the breast in relation to the type of operation performed. Br J Cancer 1948;2:7-13.
11. Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol 1994;12:2229-34. (Pubitemid 24356043)
12. Gumport SL, Lyall D, Zimany A: A radical axillary lymph node dissection for malignancy. Indications and technique. Arch Surg 1961;83:227-30.
13. Demmer F. [On the physiology of the axillary glands in breast cancer and on indications for primary breast exenteration.]. Krebsarzt 1962;17:473-85.
14. Rendall M, Patey DH. Efficiency Of Axillary Clearance In Operations For Carcinoma Of The Breast: lymphangiographic observations. Br J Surg 1965;52:565-8.
15. Gray JH. Studies of the regeneration of lymphatic vessels. J Anat 1940;74:309-35.
16. Weinberg J, Greaney EM. Identification of regional lymph nodes by means of a vital staining dye during surgery of gastric cancer. Surg Gynecol Obstet 1950;90:561-7.
17. Weinberg JA. Identification of regional lymph nodes in the treatment of bronchiogenic carcinoma. J Thorac Surg 1951;22:517-26.
18. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66. (Pubitemid 8063506)
19. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
20. Gretschel S, Bembenek A, Hünerbein M, Dresel S, Schneider W, Schlag PM. Efficacy of different technical procedures for sentinel lymph node biopsy in gastric cancer staging. Ann Surg Oncol 2007;14:2028-35. (Pubitemid 46988254)
21. Kitagawa Y, Fujii H, Mukai M, Kubota T, Otani Y, Kitajima M. Radio-guided sentinel node detection for gastric cancer. Br J Surg 2002;89:604-8. (Pubitemid 34415611)
22. Bell SW, Mourra N, Fléjou JF, Parc R, Tiret E. Ex vivo sentinel lymph node mapping in colorectal cancer. Dis Colon Rectum 2005;48:74-9.
23. Mulsow J, Winter DC, O'Keane JC, O'Connell PR. Sentinel lymph node mapping in colorectal cancer. Br J Surg 2003: 90:659-67. (Pubitemid 36760593)
24. Gretschel S, Warnick P, Bembenek A, Dresel S, Koswig S, String A et al. Lymphatic mapping and sentinel lymph node biopsy in epidermoid carcinoma of the anal canal. Eur J Surg Oncol 2008;34:890-4.
25. Hirche C, Dresel S, Krempien R, Hunerbein M. Sentinel node biopsy by indocyanine green retention fluorescence detection for inguinal lymph node staging of anal cancer: preliminary experience. Ann Surg Oncol 2010;17:2357-62.
26. van Akkooi AC, Verhoef C, van Geel AN, Kliffen M, Eggermont AM, de Wilt JH. Sentinel node biopsy for clear cell sarcoma. Eur J Surg Oncol 2006;32:996-9. (Pubitemid 44615585)
27. Andreou D, Tunn PU. Sentinel node biopsy in soft tissue sarcoma. Recent Results Cancer Res 2009;179:25-36.
28. Gipponi M, Solari N, Lionetto R, Di Somma C, Villa G, Schenone F et al. The prognostic role of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma: experience of the Genoa group. Eur J Surg Oncol 2005;31:1191-7. (Pubitemid 41819207)
29. Kett K, Varga G, Lukacs L. Direct lymphography of the breast. Lymphology 1970;3:2-12.
30. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-8.
31. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368-73. (Pubitemid 29102337)
32. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645-51.
33. Hung WK, Chan CM, Ying M, Chong SF, Mak KL, Yip AW. Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer. BrJ Surg 2005;92:1494-7. (Pubitemid 41785287)
34. Travagli JP, Atallah D, Mathieu MC, Rochard F, Camatte S, Lumbroso J et al. Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis. Eur J Surg Oncol 2003;29:403-6. (Pubitemid 36675702)
35. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T et al. Technical outcomes of sentinellymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007;8:881-8. (Pubitemid 47488052)
36. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-50. (Pubitemid 27251137)
37. Haffty BG, Ward B, Pathare P, Salem R, McKhann C, Beinfield M et al. Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol 1997;15.691-700.
38. Cady B. Is axillary lymph node dissection necessary in routine management of breast cancer? No. Important Adv Oncol 1996:251-65.
39. Bonnema J, van de Velde CJ. Sentinel lymph node biopsy in breast cancer. Ann Oncol 2002;13:1531-7. (Pubitemid 35331450)
40. Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P et al. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 2008;247:207-13. (Pubitemid 351156760)
41. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002;20:3628-36. (Pubitemid 34983222)
42. Purushotham AD, Macmillan RD, Wishart GC. Advances in axillary surgery for breast cancer -time for a tailored approach. Eur J Surg Oncol 2005;31:929-31. (Pubitemid 41671103)
43. Langer I, Guller U, Berclaz G, Kochli OR, Schaer G, Fehr MK et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 2007;245:452-61. (Pubitemid 46673142)
44. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006;98:599-609. (Pubitemid 43904843)
45. Kell MR, Burke JP, Barry M, Morrow M. Outcome of axillary staging in early breast cancer: a meta-analysis. Breast Cancer Res Treat 2010;120:441-7.
46. Liberman L. Pathologic analysis of sentinel lymph nodes in breast carcinoma. Cancer 2000;88:971-7.
47. Maaskant AJ, van de Poll-Franse LV, Voogd AC, Coebergh JW, Tutein Nolthenius-Puylaert MC, Nieuwenhuijzen GA. Stage migration due to introduction of the sentinel node procedure: a population-based study. Breast Cancer Res Treat 2009;113:173-9.
48. Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 2006;95:279-93.
49. Clarke D, Newcombe RG, Mansel RE. The learning curve in sentinel node biopsy: the ALMANAC experience. Ann Surg Oncol 2004;11:211S-5S.
50. Procaccini E, Ruggiero R, Docimo G, Iovino F, Procaccini F, De Luca R et al. Sentinel lymph node biopsy in the treatment of breast cancer. Experience in 527 cases. Minerva Chir 2007;62.93-9.
51. Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J et al. Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol 2010;17:1854-61.
52. Tousimis E, Van Zee KJ, Fey JV, Hoque LW, Tan LK, Cody HS et al. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. J Am Coll Surg 2003;197:529-35.
53. Chagpar AB, Kehdy F, Scoggins CR, Martin RC 2nd, Carlson DJ, Laidley AL et al. Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer. AmJ Surg 2005;190:557-62.
54. Sianesi M, Ceci G, Ghirarduzzi A, Del Rio P, Guazzi A, Pisanelli B et al. Use of axillary ultrasonography in breast cancer: a useful tool to reduce sentinel node procedures. Ann Ital Chir 2009;80:315-8.
55. Baruah BP, Goyal A, Young P, Douglas-Jones AG, Mansel RE. Axillary node staging by ultrasonography and fine-needle aspiration cytology in patients with breast cancer. Br J Surg 2010;97:680-3.
56. Lumachi F, Borsato S, Tregnaghi A, Ferretti G, Povolato M, Cecchin D et al. Usefulness of combined sestamibi scintimammography, axillary ultrasonography and FNA cytology in reducing the number of sentinel node procedures in patients with early-stage breast cancer. Anticancer Res 2009;29:491-4.
57. Tagaya N, Yamazaki R, Nakagawa A, Abe A, Hamada K, Kubota K et al. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg 2008; 195.850-3.
58. Murawa D, Hirche C, Dresel S, Hunerbein M. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. Br J Surg 2009;96:1289-94.
59. Hirche C, Murawa D, Mohr Z, Kneif S, Hünerbein M. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat 2010.
60. Guller U, Nitzsche EU, Schirp U, Viehl CT, Torhorst JI Moch H et al. Selective axillary surgery in breast cancer patients based on positron emission tomography with 18F-fluoro-2-deoxy-D-glucose: not yet! Breast Cancer Res Treat 2002,71:171-3.
61. Wahl RL, Siegel BA, Coleman RE, Gatsonis CG. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group. J Clin Oncol 2004;22:277-85. (Pubitemid 41095092)
62. Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, Kondo N et al. Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CD in combination with ultrasonography for axillary staging in primary breast cancer. BMC Cancer 2008;8:165.
63. Luciani A, Dao TH, Lapeyre M, Schwarzinger M, Debaecque C, Lantieri L et al. Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results. AJR Am J Roentgenol 2004;182:1059-67. (Pubitemid 38391675)
64. Reitsamer R, Peintinger F, Rettenbacher L, Prokop E. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Surg Oncol 2003;84:63-7. (Pubitemid 37247910)
65. Gimbergues P, Abrial C, Durando X, Le Bouedec G, Cachin F, Penault-Llorca F et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Ann Surg Oncol 2008;15:1316-21.
66. Wong SL, Chao C, Edwards MJ, Tuttle TM, Noyes RD, Carlson DJ et al. Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. Am Surg 2001;67:522-6.
67. Chung MH, Ye W, Giuliano AE. Role for sentinel lymph node dissection in the management of large (≥5 cm) invasive breast cancer. Ann Surg Oncol 2001;8:688-92. (Pubitemid 32952482)
68. Cox CE, Nguyen K, Gray RJ, Salud C, Ku NN, Dupont E et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 2001;67:513-9. (Pubitemid 33738842)
69. Cserni G, Bianchi S, Vezzosi V, van Diest P, van Deurzen C, Sejben I et al. Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions. Eur J Cancer 2008;44:2185-91.
70. Stitzenberg KB, Calvo BF, Iacocca MV, Neelon BH, Sansbury LB, Dressler LG et al. Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer. Am J Clin Pathol 2002;117:729-37. (Pubitemid 34457007)
71. Patani N, Mokbel K. The clinical significance of sentinel lymph node micrometastasis in breast cancer. Breast Cancer Res Treat 2009;114:393-402.
72. Langer I, Guller U, Berclaz G, Koechli OR, Moch H, Schaer G et al. Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Res Treat 2009;113:129-36.
73. Chung MA, Steinhoff MM, Cady B: Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 2002;184:310-4. (Pubitemid 35287348)
74. Bergkvist L, de Boniface J, Jönsson PE, Ingvar C, Liljegren G, Frisell J; Swedish Society of Breast Surgeons. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study. Ann Surg 2008;247:150-6.
75. Langer I, Marti WR, Guller U, Moch H, Harder F, Oertli D et al. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 2005;241:152-8. (Pubitemid 40041004)
76. Wasif N, Maggard MA, Ko CY, Giuliano AE. Underuse of axillary dissection for the management of sentinel node micrometastases in breast cancer. Arch Surg 2010;145:161-6.
77. Hsiang DJ, Yamamoto M, Mehta RS, Su MY, Baick CH, Lane KT et al. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab. Arch Surg 2007;142:855-61.
78. Straver ME, Loo CE, Alderliesten T, Rutgers EJ, Vrancken Peeters MT. Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer. Br J Surg 2010;97:1226-31.
79. Gimbergues P, Dauplat MM, Durando X, Abrial C, Le Bouedec G, Mouret-Reynier MA et al. Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patients. Ann Surg Oncol 2010;17:2132-7.
80. McLaughlin RA, Scolaro L, Robbins P, Hamza S, Saunders C, Sampson DD. Imaging of human lymph nodes using optical coherence tomography: potential for staging cancer. Cancer Res 2010;70:2579-84.
81. Vermeeren L, van der Ploeg IM, Olmos RA, Meinhardt W, Klop WM, Kroon BB et al. SPECT/CT for preoperative sentinel node localization. J Surg Oncol 2010;101:184-90.
82. Iwuchukwu OC, Wahed S, Wozniak A, Dordea M, Rich A. Recent advances in non-invasive axillary staging for breast cancer. Surg Oncol 2010 [Epub ahead of print].